We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+2.97%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.72B
AUM Growth
-$344M
Cap. Flow
-$310M
Cap. Flow %
-18%
Top 10 Hldgs %
22.96%
Holding
279
New
14
Increased
72
Reduced
169
Closed
14

Sector Composition

Rank Sector Weight
1 Technology 27.05%
2 Healthcare 26.07%
3 Industrials 15.04%
4 Consumer Discretionary 11.17%
5 Communication Services 6.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PZZA icon
126
Papa John's
PZZA
$785M
$3.23M 0.19%
46,204
-445
-1% -$37.8K
LUCK
127
Lucky Strike Entertainment
LUCK
$896M
$3.23M 0.19%
262,143
-2,297
-0.9% -$27.4K
XPEL icon
128
XPEL
XPEL
$1.31B
$3.22M 0.19%
49,992
+104
+0.2% +$6.75K
AVD icon
129
American Vanguard Corp
AVD
$66.4M
$3.2M 0.19%
170,897
+1,491
+0.9% +$31.1K
HAYN
130
DELISTED
Haynes International, Inc.
HAYN
$3.13M 0.18%
89,112
+5,785
+7% +$218K
RCM
131
DELISTED
R1 RCM Inc. Common Stock
RCM
$3.13M 0.18%
168,855
-1,677
-1% -$38.2K
ALG icon
132
Alamo Group
ALG
$2.06B
$3.08M 0.18%
25,188
+1,337
+6% +$170K
ONT
133
Onterris Inc
ONT
$546M
$3.07M 0.18%
91,261
+20,126
+28% +$798K
PRFT
134
DELISTED
Perficient Inc
PRFT
$3.06M 0.18%
47,081
+598
+1% +$49.9K
CRAI icon
135
CRA International
CRAI
$1.06B
$3.04M 0.18%
34,317
+71
+0.2% +$6.52K
ENSG icon
136
The Ensign Group
ENSG
$10.7B
$3.03M 0.18%
38,127
-431
-1% -$35.7K
DBI icon
137
Designer Brands
DBI
$333M
$3.01M 0.17%
196,798
+416
+0.2% +$6.52K
OPTN
138
DELISTED
OptiNose
OPTN
$3M 0.17%
54,720
-4,452
-8% -$244K
TCBK icon
139
TriCo Bancshares
TCBK
$1.82B
$2.99M 0.17%
67,024
+31,926
+91% +$1.5M
UPLD icon
140
Upland Software
UPLD
$14.5M
$2.97M 0.17%
36,502
+33,155
+991% +$3.67M
OPRX icon
141
OptimizeRx
OPRX
$129M
$2.94M 0.17%
198,094
+19,153
+11% +$379K
ELF icon
142
e.l.f. Beauty
ELF
$5.62B
$2.87M 0.17%
76,247
-24,990
-25% -$902K
MYRG icon
143
MYR Group
MYRG
$5.15B
$2.85M 0.17%
33,630
-5,526
-14% -$506K
THRY icon
144
Thryv Holdings
THRY
$96M
$2.85M 0.17%
124,771
+253
+0.2% +$6.3K
PLOW icon
145
Douglas Dynamics
PLOW
$982M
$2.82M 0.16%
100,784
+7,115
+8% +$217K
GNTY
146
DELISTED
Guaranty Bancshares
GNTY
$2.79M 0.16%
80,805
+667
+0.8% +$23.9K
GRBK icon
147
Green Brick Partners
GRBK
$3.04B
$2.76M 0.16%
129,015
-40,048
-24% -$987K
VMC icon
148
Vulcan Materials
VMC
$37B
$2.72M 0.16%
17,250
-486
-3% -$78.9K
CW icon
149
Curtiss-Wright
CW
$25.7B
$2.69M 0.16%
19,356
-280
-1% -$39.7K
HUBG icon
150
HUB Group
HUBG
$2.9B
$2.69M 0.16%
78,098
-18,968
-20% -$725K

Similar funds

Rice Hall James & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Rice Hall James & Associates held 279 positions worth $1.72B, down 17% from $2.07B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Rice Hall James & Associates withdrew a net $310M in Q3 2022, closing 14 positions and reducing 169 holdings. Its most notable exit was Global Blood Therapeutics, Inc., an estimated $7.39M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in TechTarget worth $8.44M.

  • Rice Hall James & Associates's largest Q3 2022 buy was TechTarget: 142,597 shares worth $8.44M.
  • Rice Hall James & Associates added most to Upland Software in Q3 2022, an estimated $3.67M increase.
  • Rice Hall James & Associates's biggest Q3 2022 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $26.8M.
  • Rice Hall James & Associates fully exited Global Blood Therapeutics, Inc. in Q3 2022, selling an estimated $7.39M.
  • Rice Hall James & Associates's ten largest holdings make up 23% of its $1.72B portfolio in Q3 2022.
  • Rice Hall James & Associates opened 14 new positions and closed 14 in Q3 2022.
  • Rice Hall James & Associates's portfolio value fell 17% quarter-over-quarter to $1.72B.

Based on Rice Hall James & Associates's 13F filing for Q3 2022, filed 1 Nov 2022.